The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
About this item
Full title
Author / Creator
Zhuo, Jianyong , Lu, Di , Lin, Zuyuan , Yang, Xinyu , Yang, Modan , Wang, Jianguo , Tao, Yaoye , Wen, Xue , Li, Huihui , Lian, Zhengxing , Cen, Beini , Dong, Siyi , Wei, Xuyong , Xie, Haiyang , Zheng, Shusen , Shen, Youqing and Xu, Xiao
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Cytokeratin 19-positive (CK19+) hepatocellular carcinoma (HCC) is an aggressive subtype characterized by early recurrence and chemotherapy tolerance. However, there is no specific therapeutic option for CK19+ HCC. The correlation between tumor recurrence and expression status of CK19 were studied in 206 patients undergoing liver transplantation for...
Alternative Titles
Full title
The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0c2f2212cdcf45f8b489bd9024689604
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0c2f2212cdcf45f8b489bd9024689604
Other Identifiers
ISSN
2041-4889
E-ISSN
2041-4889
DOI
10.1038/s41419-021-04320-4
